SMYD3 and rectal cancer: Consistent with this finding, analysis of the TCGA/GTEx CRC cohort demonstrated that SMYD3 expression was significantly higher in colon (n = 455) and rectal cancers (n = 165) than in normal colorectal tissues (n = 830), with no significant difference between colon and rectal subtypes (Figure 1B).